Comparing OraSure Technologies (OSUR) & Utah Medical Products (UTMD)
Utah Medical Products (NASDAQ: UTMD) and OraSure Technologies (NASDAQ:OSUR) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, dividends, profitability, valuation, institutional ownership and earnings.
Valuation and Earnings
This table compares Utah Medical Products and OraSure Technologies’ revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||NetIncome||Earnings Per Share||Price/Earnings Ratio|
|Utah Medical Products||$39.30 million||7.24||$12.12 million||$3.68||20.79|
|OraSure Technologies||$128.20 million||6.87||$19.72 million||$0.52||28.50|
OraSure Technologies has higher revenue and earnings than Utah Medical Products. Utah Medical Products is trading at a lower price-to-earnings ratio than OraSure Technologies, indicating that it is currently the more affordable of the two stocks.
Volatility and Risk
Utah Medical Products has a beta of 0.75, indicating that its stock price is 25% less volatile than the S&P 500. Comparatively, OraSure Technologies has a beta of 1.39, indicating that its stock price is 39% more volatile than the S&P 500.
Institutional & Insider Ownership
67.0% of Utah Medical Products shares are held by institutional investors. Comparatively, 92.9% of OraSure Technologies shares are held by institutional investors. 9.1% of Utah Medical Products shares are held by insiders. Comparatively, 6.4% of OraSure Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Utah Medical Products pays an annual dividend of $1.06 per share and has a dividend yield of 1.4%. OraSure Technologies does not pay a dividend. Utah Medical Products pays out 28.8% of its earnings in the form of a dividend.
This table compares Utah Medical Products and OraSure Technologies’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Utah Medical Products||34.31%||18.83%||16.85%|
This is a summary of current ratings and target prices for Utah Medical Products and OraSure Technologies, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Utah Medical Products||0||0||0||0||N/A|
OraSure Technologies has a consensus target price of $17.25, suggesting a potential upside of 16.40%. Given OraSure Technologies’ higher probable upside, analysts clearly believe OraSure Technologies is more favorable than Utah Medical Products.
OraSure Technologies beats Utah Medical Products on 8 of the 15 factors compared between the two stocks.
Utah Medical Products Company Profile
Utah Medical Products, Inc. (UTMD) is engaged in the business of producing medical devices that are disposable and for hospital use. The Company’s product categories include labor and delivery/obstetrics, including fetal monitoring accessories, Vacuum-Assisted Delivery Systems (VAD), and other labor and delivery tools; neonatal intensive care, including DISPOSA-HOOD, DELTRAN PLUS and GESCO; gynecology/urology/electrosurgery, including LETZ System, FINESSE+ Generator, EPITOME, PATHFINDER PLUS, HOLMIUM LASER FIBRES, LIBERTY System, ENDOCURETTE, TVUS/HSG-Cath and LUMIN, and blood pressure monitoring, including DELTRAN Disposable Pressure Transducer (DPT), and pressure monitoring accessories, components and other molded parts. UTMD markets a range of medical devices used in critical care areas, especially the neonatal intensive care unit, the labor and delivery department and the women’s health center in hospitals, as well as products sold to outpatient clinics and physician’s offices.
OraSure Technologies Company Profile
OraSure Technologies, Inc. (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types. The Company operates in two segments: OSUR and DNAG. OSUR consists of the development, manufacture and sale of diagnostic products, specimen collection devices, and medical devices. DNAG or molecular collection systems business consists primarily of the development, manufacture and sale of oral fluid collection devices that are used to collect, stabilize, and store samples of genetic material for molecular testing. It also manufactures and sells medical devices used for the removal of benign skin lesions by cryosurgery or freezing. It sells over-the-counter (OTC) cryosurgical products to consumers in North America, Europe, Central and South America, and Australia.
Receive News & Ratings for Utah Medical Products Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products Inc. and related companies with MarketBeat.com's FREE daily email newsletter.